Robert Hayman - Jan 27, 2023 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for Robert Hayman
Stock symbol
EOLS
Transactions as of
Jan 27, 2023
Transactions value $
$0
Form type
4
Date filed
1/31/2023, 07:42 PM
Previous filing
Sep 13, 2022
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock Award $0 +8.29K +20.79% $0.00 48.2K Jan 27, 2023 Direct F1
holding EOLS Common Stock 10K Jan 27, 2023 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOLS Stock Option (Right to Buy) Award $0 +11.8K $0.00 11.8K Jan 27, 2023 Common Stock 11.8K $10.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the one year anniversary of January 27, 2023, provided the reporting person remains in continuous service before the vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.
F2 The shares subject to the option will vest over a period of twelve months, with 1/12th of the shares subject to the option vesting monthly on the anniversary of January 27, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.